Literature DB >> 29174141

Stability of virus-like particles of red-spotted grouper nervous necrosis virus in the aqueous state, and the vaccine potential of lyophilized particles.

Nguyen Thi Lan1, Hyoung Jin Kim1, Hyun-Ja Han2, Deok-Chan Lee2, Bo Kyu Kang3, Sang Yoon Han3, Hyoungjoon Moon3, Hong-Jin Kim4.   

Abstract

Virus-like particles (VLPs) are multi protein complexes mimicking the structural properties of the native virus. The development of freeze-dried formulations of such complex protein structures remains a challenge. Red-spotted grouper nervous necrosis virus (RGNNV) causes mass mortality in fish culture, and RGNNV VLPs have been suggested to be promising vaccine candidates. In the present study, the stability of RGNNV VLPs in the liquid state was investigated over a 4-week period, along with the influence of freeze-drying on VLP stability. RGNNV VLPs were completely degraded after one week at 37 °C followed by 3 weeks at ambient temperature, and they were partially degraded after 4 weeks at 4 °C. Therefore, the inherent stability of RGNNV VLP in an aqueous milieu is insufficient for long-term storage. When RGNNV VLPs were freeze-dried in the presence or absence of sugar stabilizers, sorbitol was found to improve VLP stability whereas mannitol reduced it. VLP preparations freeze-dried with sorbitol or without stabilizer were as immunogenic as control (non-freeze dried) VLPs, whereas VLPs freeze-dried in mannitol were less immunogenic. These results indicate that freeze-dried RGNNV VLPs have potential as vaccines.
Copyright © 2017 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Freeze drying; Lyophilization; Nervous necrosis virus; Vaccine; Virus-like particles

Mesh:

Substances:

Year:  2017        PMID: 29174141     DOI: 10.1016/j.biologicals.2017.11.002

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  4 in total

Review 1.  Mechanisms of cellular and humoral immunity through the lens of VLP-based vaccines.

Authors:  Hunter McFall-Boegeman; Xuefei Huang
Journal:  Expert Rev Vaccines       Date:  2022-01-24       Impact factor: 5.217

Review 2.  Virus-like particle vaccines: immunology and formulation for clinical translation.

Authors:  Braeden Donaldson; Zabeen Lateef; Greg F Walker; Sarah L Young; Vernon K Ward
Journal:  Expert Rev Vaccines       Date:  2018-09-19       Impact factor: 5.217

3.  Development of a large volume concentration method for recovery of coronavirus from wastewater.

Authors:  Brian R McMinn; Asja Korajkic; Julie Kelleher; Michael P Herrmann; Adin C Pemberton; Warish Ahmed; Eric N Villegas; Kevin Oshima
Journal:  Sci Total Environ       Date:  2021-02-09       Impact factor: 7.963

4.  Long-Term Protection and Serologic Response of European Sea Bass Vaccinated with a Betanodavirus Virus-Like Particle Produced in Pichia pastoris.

Authors:  Sofie Barsøe; Anna Toffan; Francesco Pascoli; Ansgar Stratmann; Tobia Pretto; Andrea Marsella; Mériem Er-Rafik; Niccolò Vendramin; Niels J Olesen; Dagoberto Sepúlveda; Niels Lorenzen
Journal:  Vaccines (Basel)       Date:  2021-05-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.